Facebook
Twitter
LinkedIn
Forward
Genetic sequencing technologies are increasingly applied in the oncology setting for a variety of purposes. Genetic testing of tumor specimens can help clarify a diagnosis and inform targeted therapies. Kate Foreman, MS, CGC helps us navigate this field.
|
In this webinar, Angela Smith, MD, MS, FACS discusses the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.
|
This presentation focuses on the unique psychosocial complications related to being diagnosed with - and treated for - cancer during the COVID pandemic.
|
Isiah Zipple, CTR provides a detailed explanation of key cancer registry functions and highlight the data it contains.
|
Cancer and cancer treatments can affect patient’s memory, concentration, and other aspects of cognition.
|
Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatme
|
Lyn Filip, RN, BSN, OCN will provide an introduction into the benefits of Pet Therapy in a clinical oncology setting.
|
Cindy Kelly, FNP-BC, ACHPN, and Vineeta Rao, PharmD, BCPS, review opioid and nonopioid treatment options for cancer-related pain. Their presentation addresses patients with cancer and substance use disorder and also cancer patients that are in remission, but who still present with persistent pain.
|
Farrell Wiggins MS, OTR/L, and Alexis Petteway, MS, OTR/L, provide insight into Occupational Therapy’s unique role in cancer rehabilitation. They explore the benefits of receiving OT in both the inpatient and outpatient settings. Importantly, they also discuss the how occupational therapists measure and address cancer and chemotherapy related symptoms and occupational challenges in cancer survivors.
|
Patti Morfeld, RN, BSN, OCNm discusses how to provide patient centered care for LGBTQ patients and families from registration through diagnosis, treatment and survivorship.
|